Cargando…
Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
BACKGROUND: Recent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health fields, uses nanoparticles for several applications such as imaging, diagnostic, targeted cancer thera...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038981/ https://www.ncbi.nlm.nih.gov/pubmed/35467307 http://dx.doi.org/10.1186/s41181-022-00161-4 |
_version_ | 1784694021114822656 |
---|---|
author | Pijeira, Martha Sahylí Ortega Viltres, Herlys Kozempel, Jan Sakmár, Michal Vlk, Martin İlem-Özdemir, Derya Ekinci, Meliha Srinivasan, Seshasai Rajabzadeh, Amin Reza Ricci-Junior, Eduardo Alencar, Luciana Magalhães Rebelo Al Qahtani, Mohammed Santos-Oliveira, Ralph |
author_facet | Pijeira, Martha Sahylí Ortega Viltres, Herlys Kozempel, Jan Sakmár, Michal Vlk, Martin İlem-Özdemir, Derya Ekinci, Meliha Srinivasan, Seshasai Rajabzadeh, Amin Reza Ricci-Junior, Eduardo Alencar, Luciana Magalhães Rebelo Al Qahtani, Mohammed Santos-Oliveira, Ralph |
author_sort | Pijeira, Martha Sahylí Ortega |
collection | PubMed |
description | BACKGROUND: Recent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health fields, uses nanoparticles for several applications such as imaging, diagnostic, targeted cancer therapy, drug and gene delivery, tissue engineering, and theranostics. RESULTS: Here, we overview the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and radionuclide therapy. Nanostructured radiopharmaceuticals of technetium-99m, copper-64, lutetium-177, and radium-223 are discussed within the scope of this review article. CONCLUSION: Nanoradiopharmaceuticals may lead to better development of theranostics inspired by ingenious delivery and imaging systems. Cancer nano-theranostics have the potential to lead the way to more specific and individualized cancer treatment. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9038981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-90389812022-05-07 Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology Pijeira, Martha Sahylí Ortega Viltres, Herlys Kozempel, Jan Sakmár, Michal Vlk, Martin İlem-Özdemir, Derya Ekinci, Meliha Srinivasan, Seshasai Rajabzadeh, Amin Reza Ricci-Junior, Eduardo Alencar, Luciana Magalhães Rebelo Al Qahtani, Mohammed Santos-Oliveira, Ralph EJNMMI Radiopharm Chem Review BACKGROUND: Recent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health fields, uses nanoparticles for several applications such as imaging, diagnostic, targeted cancer therapy, drug and gene delivery, tissue engineering, and theranostics. RESULTS: Here, we overview the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and radionuclide therapy. Nanostructured radiopharmaceuticals of technetium-99m, copper-64, lutetium-177, and radium-223 are discussed within the scope of this review article. CONCLUSION: Nanoradiopharmaceuticals may lead to better development of theranostics inspired by ingenious delivery and imaging systems. Cancer nano-theranostics have the potential to lead the way to more specific and individualized cancer treatment. GRAPHICAL ABSTRACT: [Image: see text] Springer International Publishing 2022-04-25 /pmc/articles/PMC9038981/ /pubmed/35467307 http://dx.doi.org/10.1186/s41181-022-00161-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Pijeira, Martha Sahylí Ortega Viltres, Herlys Kozempel, Jan Sakmár, Michal Vlk, Martin İlem-Özdemir, Derya Ekinci, Meliha Srinivasan, Seshasai Rajabzadeh, Amin Reza Ricci-Junior, Eduardo Alencar, Luciana Magalhães Rebelo Al Qahtani, Mohammed Santos-Oliveira, Ralph Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology |
title | Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology |
title_full | Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology |
title_fullStr | Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology |
title_full_unstemmed | Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology |
title_short | Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology |
title_sort | radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038981/ https://www.ncbi.nlm.nih.gov/pubmed/35467307 http://dx.doi.org/10.1186/s41181-022-00161-4 |
work_keys_str_mv | AT pijeiramarthasahyliortega radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT viltresherlys radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT kozempeljan radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT sakmarmichal radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT vlkmartin radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT ilemozdemirderya radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT ekincimeliha radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT srinivasanseshasai radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT rajabzadehaminreza radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT riccijunioreduardo radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT alencarlucianamagalhaesrebelo radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT alqahtanimohammed radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology AT santosoliveiraralph radiolabelednanomaterialsforbiomedicalapplicationsradiopharmacyintheeraofnanotechnology |